Showing results (1-10 of 57) with videos related to
Sort By:
Pageof 6
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 10, 2012
Potential for clinical radionuclide-based imaging and therapy of common cancers expressing EGFR-family receptorsJörgen CarlssonActa Oncologica (Stockholm, Sweden)|July 13, 2004
A limiting factor for the progress of radionuclide-based cancer diagnostics and therapy--availability of suitable radionuclidesVladimir Tolmachev, Jörgen Carlsson, Hans LundqvistActa Oncologica (Stockholm, Sweden)|December 4, 2003
Radiation therapy through activation of stable nuclidesJörgen Carlsson, Eva Forssell-Aronsson, Bengt Glimelius, et al.International Journal of Oncology|July 19, 2008
Effects of radiation on growth of two human tumour cell lines surviving a previous high dose, low dose-rate, radionuclide exposureLova Segerström, Bo Stenerlow, Veronika Eriksson, et al.European Journal of Nuclear Medicine and Molecular Imaging|May 24, 2006
Requirements regarding dose rate and exposure time for killing of tumour cells in beta particle radionuclide therapyJörgen Carlsson, Veronika Eriksson, Bo Stenerlöw, et al.Acta Oncologica (Stockholm, Sweden)|December 4, 2003
Therapy with radiopharmaceuticalsJörgen Carlsson, Eva Forssell-Aronsson, Bengt Glimelius, et al.European Journal of Nuclear Medicine and Molecular Imaging|May 13, 2003
Treatment of cultured glioma cells with the EGFR-TKI gefitinib ("Iressa", ZD1839) increases the uptake of astatinated EGF despite the absence of gefitinib-mediated growth inhibitionAsa Liljegren Sundberg, Ylva Almqvist, Vladimir Tolmachev, et al.International Journal of Molecular Medicine|October 10, 2002
EGF and dextran-conjugated EGF induces differential phosphorylation of the EGF receptorMaria Hägg, Asa Liljegren, Jörgen Carlsson, et al.Oncology Letters|February 14, 2018
Analysis of radiation effects in two irradiated tumor spheroid modelsAfkar Al-Ramadan, Anja C Mortensen, Jörgen Carlsson, et al.Nuclear Medicine and Biology|August 29, 2006
A novel 125I-labeled daunorubicin derivative for radionuclide-based cancer therapyLudger M Ickenstein, Katarina Edwards, Stefan Sjöberg, et al.Pageof 6